Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab
Lize Wang(Peking University), Tao Ouyang(Peking University), Yang Zhang(Dalian Medical University), Jinfeng Li(Hebei Medical University), Zhaoqing Fan(Daqing Oilfield General Hospital), Yuntao Xie(Peking University), Tianfeng Wang(Peking University), Yingjian He(Peking University)
Cited by 5
Related Papers
TM-align: a protein structure alignment algorithm based on the TM-score
|Nucleic Acids Research|2005|3.9k
How significant is a protein structure similarity with TM-score = 0.5?
|Bioinformatics|2010|1.1k
The Biogenesis of Nascent Circular RNAs
|Cell Reports|2016|694
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
|Nucleic Acids Research|2017|551
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272